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Background: Concerns about test administration, reliability estimations, content and internal structure
(dimensionality) of available shoulder measures for people with proximal humeral facture led to the development
of a new clinician-observed outcome measure: the Shoulder Function Index (SFInX). The SFInX measures shoulder
function by judgement of actual ability to perform daily tasks in which the shoulder is involved. Patients and health
professionals had input into the instrument development, and Rasch analysis was used to create a unidimensional,
interval-level scale. This study comprehensively evaluated the measurement properties of the SFInX in people
recovering from a proximal humeral fracture.
Methods: Data were collected on 92 people [79 women, mean age 63.5 years (SD13.9)] who sustained a proximal
humeral fracture within the previous year on three occasions to allow for evaluation of the following measurement
properties: construct validity (convergent, discriminant and known-groups validity), longitudinal validity
(responsiveness), intra-rater reliability (one week retest interval), and inter-rater reliability (n = 20 subgroup; two
independent raters). Comparative measures were Constant Score and Disabilities of the Arm Shoulder and Hand
(DASH) and discriminative measure was a mental status questionnaire. Minimal clinically important difference,
floor and ceiling effects and feasibility of the SFInX were also evaluated. A priori hypotheses were formulated
where applicable.
Results: Results for construct validity testing supported hypothesised relationships (convergent validity
r = 0.75–0.89 (Constant Score and DASH); discriminant validity r = −0.08 (mental status); known-groups validity
r = 0.50). For longitudinal validity, lower correlations (r = 0.40–0.49) than hypothesised (r = 0.50–0.70) were
found. The SFInX scores changed more (10.3 points) than other scales, which could indicate that the SFInX is
more responsive than the comparative measures. Intra-rater and inter-rater reliability found ICCs of 0.96
(95 % CI 0.94–0.97) and 0.91 (95 % CI 0.63–0.97) respectively, with low measurement error (SEM = 3.9–5.8/100).
A change of 11–12 points (out of 100) was indicative of a clinically important difference.
Conclusions: The SFInX is a feasible outcome measure which clinicians can use to reliably measure and
detect clinically important changes in the construct of ‘shoulder function’, the ability to perform activities in
which the shoulder is involved, in people recovering from a proximal humeral fracture.
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Table 1 Selection criteria of participants
Inclusion criteria
- 18 years or older
- Isolated proximal humeral fracture, or proximal humeral fracture-dislocation
with similar clinical presentation after reduction
- Available for recruitment within one year (365 days) post-fracture
- Any treatment received for proximal humeral fracture before or during
study participation
- Ability to complete English-language questionnaires and to follow
simple instructions in English
- Short Portable Mental Status Questionnaire score 6–10 (indicates intact
or mildly impaired cognitive functioning)
Exclusion criteria
- Other serious medical issues from the trauma (e.g. hip fracture, wrist
fracture, nerve lesion, traumatic brain injury, muscle ruptures)
- Potentially confounding medical conditions (e.g. hemiplegic arm,
previous shoulder surgery, re-fracture, severe rheumatoid arthritis)
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Fractures of the proximal humerus are the third most
common limb fracture in older people [1, 2], and the
incidence is expected to increase because of the ageing
population [3]. A proximal humeral fracture is debilitat-
ing for the person directly after the trauma with loss of
arm function and severe pain, and often results in on-
going disability with a prolonged period of recovery and
rehabilitation [4, 5].
To monitor a patient’s shoulder function during re-
habilitation after a proximal humeral fracture, measures
with sufficient reliability that can detect change in shoul-
der function are required. Many different measures
related to the shoulder exist [6], varying from single
range of motion measurements to multi-item question-
naires focussing on activities, shoulder pain and social
participation. However, impairment measures do not ne-
cessarily reflect daily functioning of a patient, and sub-
jective measures provide a different insight into the
patient’s problem than objective or performance-based
measures [7–9]. A systematic review [10] found that
psychometric properties of shoulder outcome measures
were limited in evaluating people recovering from a
proximal humeral fracture. Knowledge is therefore lack-
ing regarding what outcome measures are sufficiently
reliable and valid to measure shoulder function, and are
able to measure change over time in those patients. A
recent study [11] performed a head-to-head psycho-
metric evaluation of five shoulder outcome measures (in-
cluding Constant Score, Disabilities of the Arm Shoulder
and Hand (DASH), Oxford Shoulder Score) and provided
some evidence for construct validity and test-retest reli-
ability of these measures, but also highlighted measure-
ment concerns regarding their absolute reliability. For
example, the DASH had wide limits of agreement with 15
to 21 out of 100 points difference required to exceed
measurement error. The study also highlighted issues with
the measures’ content and structure, some of which had
also been reported by others [12–14]. For example,
multiple measurement dimensions are combined into
a single outcome score, subjective and objective mea-
sures are combined and lacking of standardisation.
Such limitations could influence the quality of meas-
urement, the evaluation of treatment effects and the
monitoring of progress of individuals recovering from
a proximal humeral fracture.
For these reasons, a new outcome measure for shoulder
function was developed: the Shoulder Function Index
(SFInX) [15, 16], a clinician-observed outcome measure
developed for people with a proximal humeral fracture
within the Activities domain of the International Classifi-
cation of Functioning, Disability and Health framework
[17]. A patient is asked to perform activities, which are
judged by a clinician on successful completion. Since it isbased on the actual ability to perform tasks in which
the shoulder is involved, it is reflective of the daily
limitations a person has after a proximal humeral
fracture. The SFInX was developed with input from
patients in the target population and health profes-
sionals. Rasch analysis was used to create an interval-
level scale that is unidimensional capturing ‘shoulder
function’ as reflected by the tasks [15, 16]. However,
further evaluation of measurement properties is re-
quired to evaluate the potential for the SFInX to
monitor the functional progress of individuals and as
an outcome measure in clinical trials of interventions
for people with a proximal humeral fracture.
The aim of the current study was to evaluate the meas-
urement properties of the SFInX in people recovering
from a proximal humeral fracture. In addition, floor or
ceiling effects and clinical feasibility were examined.
Methods
A prospective longitudinal study to evaluate measurement
properties in people with a proximal humeral fracture was
conducted. Ethics approval was obtained from two rele-
vant human ethics committees [La Trobe University Hu-
man Ethics Committee (FHEC11-113) and Eastern Health
Human Ethics Committee (LR86-1011)], and all partici-
pants provided written informed consent.
Participants
Data from participants who took part in the development
study of the SFInX [15, 16] were used to evaluate the
measurement properties. Clinical testing was performed
with a larger set of items (n = 19) which were reduced
during development to 13 items in the final SFInX [15,
16]. People with a proximal humeral fracture were
identified from three metropolitan hospitals (Victoria,
Australia). Potentially eligible participants were mailed
an invitation to take part in the study, and non-responders
were followed up by phone. Interested individuals were
screened over the phone against eligibility criteria (Table 1).
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recruitment hospitals or, if they preferred, were offered
home visits.
Sample sizes were based on requirements for Rasch
analysis [18]. As part of the development of the SFInX
[15, 16], we aimed to recruit a consecutive sample of
n ≥ 75. With a drop out of up to 25 %, a sample size of
56 would still allow for adequate estimation of the intra-
rater reliability coefficients with sufficiently precise con-
fidence intervals [19, 20].
A convenience sub-group of participants who attended
one of the recruitment sites were also invited to be
part of the inter-rater reliability study. Based on cal-
culations from Walter et al. [19], we aimed to recruit
a sample of n ≥ 19 for estimation of the inter-rater
reliability coefficients.
Measurement protocol and outcome measures
Data were collected on three occasions: an initial assess-
ment within 1 year post-fracture and a follow-up assess-
ment 6 weeks later (Table 2). One week later, a third
assessment for intra-rater reliability was performed. This
one-week interval was considered sufficient to minimise
the clinician’s recall of previous results, and participants’
shoulder function was expected to be stable. Assessment
sessions took 30–45 min.
With regards to inter-rater reliability study, a second
rater conducted a second assessment of the SFInX
during one of the visits of a sub-group. The first rater
was a physiotherapist with 5 years of clinical experience
and was the developer of the SFInX. The second rater
was a senior physiotherapist with 20 years of experience
in the clinical assessment and treatment of the shoulder.
The second rater had no previous experience with the
SFInX, was provided with the SFInX manual whichTable 2 Overview of measurement protocol and related measurem
Recruitment Fol
General information Demographic data, QoL
‘Shoulder function’ DASH, SFInX, Constant Score DA




Intra-rater reliability SFInX ✓
Inter-rater reliability SFInXa ✓ ✓
Validity
Convergent ✓ ✓
Discriminant and Known-groups ✓
Longitudinal (or responsiveness) ✓ ✓
MCID ✓
a: paired ratings were collected at the same assessment pointincluded descriptors and scoring instructions, but had
no specific training in the SFInX prior to the study. This
method was employed since training is usually not given
when using an outcome measure described in the litera-
ture, and might therefore better reflect the agreement
between a novice user of the SFInX (second rater) and a
more experienced rater (developer of the SFInX). The
assessments by the two raters were conducted in the
same clinical environment, a maximum of 15 min apart,
and administered in a blinded and independent manner.
The two raters administrated the SFInX for this study in
random order to control for potential rater effects, such as
influence on behaviour or expectations of the participant.
Characteristics of the participants were gathered through
interview and completion of short questionnaires regarding
the cause of fracture, preferred/dominant side, independent
living status [21]. Overall health-related quality of life was
measured using the EuroQoL-5D and EuroQoL-VAS [22].
Based on x-rays, fractures were classified by an orthopaedic
consultant according to three classifications systems for
comprehensive description of fracture types: the Neer [23],
AO [24] and Codman-Hertel [25] classifications.
Comparison measures used as part of this measurement
properties evaluation were the Disabilities of the Arm,
Shoulder and Hand and Constant Score for convergent
validity, the Short Portable Mental Status Questionnaire
for discriminant validity and a ‘global rating of change’
scale for minimal clinically important difference.
Shoulder Function IndeX
The SFInX is a 13-item clinician-observed outcome meas-
ure that evaluates ‘shoulder function’ [15, 16]. A clinician
observes the performance of a patient on each item, and
judges, based on category descriptions, whether the tasks
were completed successfully. The scoring categories forent properties evaluation
low up 1 (6 weeks later) Follow up 2 (7 weeks later)
SH, SFInX, Constant Score DASH, SFInX, Constant Score
erall perception of change’-scale ‘Overall perception of change’-scale
low up 1 Follow up 2
✓
✓
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middle ‘partially able’ category, which is chosen when
compensation is used to complete the task. Total raw
scores are converted to a 0–100 interval level SFInX
score using the conversion table on the assessment
form (Appendix). On this converted scale, 0 points
means ‘unable to perform any activity successfully to
any extent’ and 100 points means ‘able to perform all
activities successfully’.
The SFInX was developed for people with a proximal
humeral fracture [15, 16]. Patients and clinicians who
treat people with a proximal humeral fracture were
actively involved in its development including item gen-
eration and providing feedback at multiple stages during
the development process. This increased the face and
content validity of the outcome measure. Rasch analysis
was performed on the 13-item SFInX which confirmed a
unidimensional structure providing evidence of structural
(construct) validity.
Disabilities of the Arm, Shoulder and Hand (DASH)
questionnaire
The DASH [26] is a multidimensional [14] 30-item patient-
reported questionnaire evaluating disability of the upper
extremity. The Australian version of the DASH was used
([www.dash.iwh.on.ca]). Items relate to daily activities (21
items; ICF Activities), symptoms (6 items; ICF Body func-
tions) and social/role function (3 items; ICF Participation
and Personal Factors), and participants are asked to reflect
on “the past week”. Item scores are on a 5-point ordinal
scale. Recommendations of the developers were followed
with regards to missing items (maximum of three) [26].
Total scores range from 0 to 100, where 0 indicates “no dis-
ability” and 100 “totally disabled”.
Available psychometric information for the DASH in
people with a proximal humeral fracture provides some
evidence of convergent validity and longitudinal validity
(compared with, for example, Oxford Shoulder Score,
Constant Score and EuroQol) [11, 21]. Test-retest reli-
ability (ICC2,1) was 0.87 (95 % CI 0.53 to 0.97) [11].
Constant score
The Constant Score [27, 28] is an impairment-focussed
shoulder outcome measure that comprises four parts.
The components ‘Pain’ (interval level visual analogue
scale from 0 to 15 points; ICF Body Functions) and
‘Activities of Daily Living function’ (ordinal scales total-
ling 0 to 20 points; ICF Body Functions and Participa-
tion) are patient-reported evaluating “the last 24 h”,
while ‘range of motion’ (ordinal scales totalling 0 to 40
points; ICF Body Functions) and ‘strength’ in 90° abduc-
tion (interval level scale from 0 to 25 points; ICF Body
Functions) are clinician-administered. The possible total
score range is 0 to 100 points, where 100 indicates‘normal’ function. The revised protocol including hand-
ling of missing data [27] was followed, with the exception
that a hand-held dynamometer (Lafayette Manual Muscle
Test System) was used for measuring the ‘strength’ com-
ponent, since it was more feasible and more common in
daily practice than an Isobex® machine [27]. Participants
were in a sitting position on an armless chair with back
support during testing.
Three studies performed psychometric evaluation of the
Constant Score in people with a proximal humeral fracture,
providing evidence for convergent validity [11, 29, 30], and
longitudinal validity [11] (compared with, for example,
Oxford Shoulder Score, Neer Score and DASH). Test-retest
reliability (ICC2,1) was 0.91 (95 % CI 0.53 to 0.97) [11].
Short portable mental status questionnaire
Discriminant validity testing compared SFInX scores
with raw scores of the Short Portable Mental Status
Questionnaire [31], which has ten items (each scored as
correct or incorrect) that reflect cognitive functioning.
Scores range from 0 to 10, with a higher score (more
correct answers) indicating better cognitive function.
Although none of the patients were excluded based on
this criterion, this questionnaire was also used as screen-
ing tool for cognitive impairment and therefore partici-
pants were required to score 6 or more points (Table 1).
Global rating of change scale
A 15-point ‘global rating of change’ scale [32] was used
as an anchor to determine the minimal clinically im-
portant difference (MCID) of the SFInX. The question
participants were asked on paper to answer was “Since
your last measurement 6 weeks ago, how much change
has there been in the function of your fractures shoul-
der?”. Scoring options ranged from ‘-7 a very great deal
worse’ through ‘0 no change’ to ‘+7 a very great deal
better’. Interpretation of the scores [33] were: 0 and ±1
were considered ‘no change’, ±2 and ±3 a ‘small change’
and equivalent to the MCID, ±4 and ±5 a ‘moderate
change’, and ±6 and ±7 a ‘large change’.
Data analysis
Statistical Package for Social Sciences version 19 [34] and
Microsoft Excel (Microsoft, Redmond, WA, USA) were
used for statistical analyses. Data were tested for and
fulfilled assumptions for parametric calculations (Shapiro-
Wilk test). Descriptive statistics were used to describe
sample characteristics. Change scores of the outcome
measures between initial assessment and first follow up
were calculated and evaluated with paired t-tests for
significance testing of change and evaluated with the
Cohen’s d effect size [35] for head-to-head comparison of
change measured by the outcome measures. Psychometric
terminology, analyses and reporting of results followed
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[36, 37] and the quality assessment checklist from the
COSMIN initiative [38, 39]. A priori hypotheses were
formulated where applicable.
Reliability and measurement error
Intra-rater reliability and inter-rater reliability
Using total SFInX scores, intra-class correlation coeffi-
cients (ICC2,1) for agreement with 95 % confidence inter-
vals (95 % CI) were calculated as a relative measure of
reliability [40–42].
Measurement error
As an absolute measure of reliability, several related statis-
tics were used to present estimates of measurement error:
Standard Error of Measurement (SEM; SEM = SDbaseline *
√(1-ICC2,1)), Minimal Detectable Change at 95 % confi-
dence (MDC95; MDC95 = SEM * √2 * 1.96) and Bland
and Altman’s Limits of Agreement (LoA; mean differ-
ence ± 1.96*SDdifference) [43].
Inter-rater item-rating agreement
Agreement of item ratings between raters was calculated
per item using Cohen’s kappa [44] for dichotomous items,
and (quadratic) weighted kappa for polytomous items
[45]. In addition, percentage agreement was calculated.
Construct validity
Construct validity was evaluated as convergent, discrim-
inant and known-groups validity.
Convergent validity, or associations between outcome
measures aiming to measure the same construct of
shoulder function, was evaluated by calculating Pearson’s
product–moment correlation coefficient (r) between
total scores of the SFInX and DASH, and the Constant
Score. We hypothesised negative (DASH) and positive
(Constant Score) linear correlations of moderate magni-
tude (r = 0.50–0.70), since the comparison measures also
include constructs from the ICF Body Functions domain.
Convergent validity was collected at two time points, at
initial assessment and at follow-up assessment 6 weeks
later. Evaluation at the second time point was completed
because the data were easily collected and to determine
if estimates of convergent validity were stable during the
clinical course after fracture.
Discriminant validity, or the absence of association
between outcome measures aiming to measure different
constructs, was evaluated by calculating Pearson’s r
between total scores of the SFInX and Short Portable
Mental Status Questionnaire [31]. We hypothesised neg-
ligible or weak (r = −0.30 to 0.30) correlations.
Known-groups or extreme groups validity is a form of
validation in which mean scores on an outcome measure
are shown to significantly differ between groups thatwould be expected to differ on the basis of a specific
characteristic [36]. We hypothesised significantly lower
(independent t-test, p < 0.05) SFInX scores for people
within three months post-fracture than scores for people
more than nine months post-fracture. In addition, a moder-
ate positive linear correlation (r = 0.40–0.60) was hypothe-
sised between SFInX scores and time post-fracture.
Longitudinal validity (responsiveness)
To determine the ability to detect change in shoulder
function over time, Pearson’s r between change scores
[38, 39] of the SFInX and DASH, and the Constant
Score were calculated. We hypothesised negative (DASH)
and positive (Constant Score) linear correlations of mod-
erate magnitude (r = 0.50–0.70) between change scores,
since the comparison measures also include constructs
from the ICF Body Functions domain.
Other characteristics
Two methods were used to determine the minimal clin-
ically important difference (MCID). The anchor-based
method used a ‘global rating of change’ scale [32]. Scores
of ±2 and ±3 were considered a ‘small change’ and
equivalent to the MCID [33]. The distribution-based
method followed Norman et al. [46] who proposed half
a standard deviation of scores at baseline as a good esti-
mate for the MCID.
Although higher floor or ceiling effect thresholds
have been used in studies with people with a prox-
imal humeral fracture [21], we followed McHorney
and Tarlov [47] who defined ‘problematic’ as >15 %
of the sample receiving the lowest or highest score
possible.
Feasibility was evaluated as administration time and
equipment required for the SFInX.
Results
Between February 2012 and January 2013, data were
collected on 92 people with a proximal humeral fracture,
who were recruited on average 26 weeks (SD15) post-
fracture (range 5–52) (Table 3). The cause of fracture
was a simple fall in 71 participants (77 %), and a high
energy trauma in 21 participants (23 %). Nine people
(10 %) had sustained a fracture-dislocation, which after
reduction had a similar clinical course to an isolated
proximal humeral fracture. Home visits were made for
25 out of the 92 (27 %) initial assessments. Eighty-one
participants (88 %) were available for the 6-week
follow up measurement (mean 42.4 days, SD 5.9). One
week later (mean 6.8 days, SD 1.8) 74 (80 %) parti-
cipants were re-assessed (Fig. 1). Reasons for loss to
follow up were work commitments, holidays or no
further interest.
Table 3 Baseline characteristics of sample (n = 92)
Characteristics no. (%) or Mean ± SD (range)
Participants 92 (100 %)
men 13 (14 %)
women 79 (86 %)
Age (years) 63.5 ± 13.9 (23–92)
Living situation
alone 23 (25 %)
with spouse/family 69 (75 %)
EuroQoL
5D (0–1) 0.68 ± 0.18 (0.15-1.0)
VAS (0–100) 76.5 ± 14.4 (30–100)
Time after fracture (weeks) 26.5 ± 15.1 (5–52)
(¼ yearly distribution) 20, 30, 19, 23
Fracture side
Right 42 (46 %)
Left 50 (54 %)
Fracture of dominant side
Yes 44 (48 %)
No 48 (52 %)
Fracture management
Conservative 74 (80 %)
Surgical ORIF 16 (17 %)
Hemi 2 (2 %)
Fracture classifications no. (%) or fracture type (no.)
AO Classification A 53 (58 %)
1.1 (11), 1.2 (4), 1.3 (4)
2.1(13), 2.2(4), 2.3(9)
3.1 (2), 3.2 (4), 3.3 (2)
B 36 (39 %)
1.1 (23), 1.2 (1)
2.1 (5), 2.3 (6), 3.2 (1)
C 3 (3 %)
1.1 (1), 2.1 (1), 3.2 (1)
Neer Classification 2-part 55 (60 %)
2FD ant (4) 2GT (15)
2aSN (22), 2bSN (9), 2cSN (5)
3-part 35 (38 %)
3FD ant (2), 3GT (31), 3LT (2)
4-part 2 (2 %)
4-part (2)
Hertel Classification 1 (30), 2 (1), 3 (19), 7 (32)
8 (1), 9 (5), 10 (1), 12 (3)
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at time of recruitment (Table 3). The SFInX, DASH and
Constant Score indicated that participants had reducedshoulder function at this time point. Differences in
average total scores at the 6-week follow up assessment
showed an improvement in shoulder function (Table 4).
Measurement properties of the SFInX
Reliability and measurement error
Data for intra-rater reliability were available from 74
participants who completed both 6 and 7 week follow
up assessments. The ICC2,1 for agreement was 0.96 (95 %
CI 0.94 to 0.97). The SEM was 3.9 points (out of 100) and
MDC95 was 10.8 points. Figure 2 shows the Bland and
Altman-plot providing the mean difference (0.1 points,
SD5.5) between assessments and the Limits of Agreement
(−10.6 to 10.8). As can be seen in Fig. 2, these data
included one outlier who increased their score by 21
points when retested one week later.
Data for inter-rater reliability from a sub-group of 20
participants yielded an ICC2,1 for agreement of 0.91 (95 %
CI 0.63 to 0.97). Total scores between raters were com-
pared with Bland and Altman-analysis (mean difference
5.1 (SD6.3), Limits of Agreement −7.3 to 17.4; random
error estimation 12.3). Figure 3 shows the significant
systematic difference of 5.1 points (95 % CI 2.1 to 8.0;
t(df) = 3.59(19), p < 0.01).
Agreement of category ratings between raters
ranged from k = 0.42 to 1.00 and percentage agree-
ment of 40–100 % (Table 5). Item 3 ‘washing back of
the opposite shoulder’ was the item with the most
different ratings. Rater 2 rated 12 out of 20 partici-
pants higher than Rater 1 on item 3, and agreed on
the remaining eight. The difference in scoring on this
item was responsible for the low kappa and system-
atic difference found with the Bland and Altman-
analyses. Wording of category descriptions was subse-
quently altered in the final 13-item version of the
SFInX to aim for higher inter-rater reliability and
inter-rater item-rating agreement.
Construct validity
Providing evidence of convergent validity, correla-
tions of the SFInX scores with the DASH and Con-
stant Score at baseline (n = 92) were −0.78 and 0.89
(p < 0.01) respectively, which were somewhat higher
than hypothesised. At the 6-week follow up assess-
ment (n = 81) the correlations were −0.75 and 0.87
(p < 0.01), respectively.
Discriminant validity testing confirmed the hypothesis
of no correlation (r = −0.08, p = 0.44) between the SFInX
and Short Portable Mental Status Questionnaire.
Known-groups validity was evaluated by comparing
initial SFInX scores between people ≤3 months post-
fracture (n = 21; mean SFInX score 41.4, SD21.1) and
those ≥9 months post-fracture (n = 23; mean SFInX
score 75.1, SD20.5). This difference of 33.7 points was
Fig. 1 Flowchart of participants in the study
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a significant moderate correlation (r = 0.50, p < 0.01)
between time post-fracture and total SFInX score
was found.
Longitudinal validity (responsiveness)
Analyses of longitudinal validity found weaker correla-
tions between change scores (difference between initial
and 6 week follow-up) than hypothesised. SFInX change
scores correlated with changes in the DASH (r = −0.40,
p < 0.01) and the Constant Score (r = 0.49, p < 0.01).Table 4 Shoulder function outcome measure scores at recruitment
Recruitment (n = 92) 6 week follow up (n = 81) d
SFInX v1.0 (0–100) 62.1 (23.4) 71.9 (18.9) 1
DASH (0–100)b 71.6 (21.1) 77.3 (19.1) 6
Constant (0–100) 52.2 (20.2) 60.4 (18.3) 9
aData from n=81 of whom data from two assessments were available, was used to
paired t-test
SFInX v1.0, Shoulder Function IndeX version 1.0
DASH, Disabilities of Arm, Shoulder and Hand questionnaire (bscores have been rev
disability”)
Constant, Constant ScoreTable 4 shows the SFInX scores changed more (10.3
points), relative to the scale width of 100, than the
DASH (6.8/100 points) or Constant Score (9.0/100
points), which could mean that the SFInX is more re-
sponsive to change in ‘shoulder function’ than the other
measures. A subgroup of patients (n = 20) that was re-
cruited ≤3 months post-fracture and reassessed 6 weeks
later, was analysed and found similar correlations be-
tween change scores (r = 0.43–0.46) to those reported in
the full sample. Also in this subgroup the SFInX had the
largest mean change scores.and 6 week follow up (values are mean (SD))
ifference in pointsa Effect size (Cohen’s d) Paired t-test
0.3 (14.0) 0.44 t(df) = 6.62(80), p < 0.001
.8 (11.9) 0.31 t(df) = 5.10(80), p < 0.001
.0 (10.4) 0.44 t(df) = 7.81(80), p < 0.001
calculate the difference in points and effect sizes, and used to perform the
ersed to facilitate comparison of total scores; 100 points indicates “no
Fig. 2 Bland and Altman-plot with 95 % Limits of Agreement for SFInX total score absolute agreement between retest sessions (Assessment 2
and 3; full black dots represent change scores of two or more participants)
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The anchor-based and distribution-based methods used
to estimate the MCID for improvement provided similar
values. Using the average SFInX score difference of people
reporting a ‘small change’ (n = 21), the anchor-based
MCID was 10.3 points (out of 100). The distribution-
based MCID was 11.7 points (half the SDbaseline of 23.2).
The MCID for deterioration was not calculated since only
2 of the 81 participants (2.5 %) reported more limitations
from the shoulder at the 6-weeks follow up assessment.
Using the cut-off percentage of >15 %, the SFInX did not
show a problematic floor or ceiling effect. At recruitment 2Fig. 3 Bland and Altman-plot with 95 % Limits of Agreement for SFInX tot
change scores of two participants)of 92 participants (2 %) received the lowest and 10 partici-
pants (11 %) the highest SFInX score possible. Six weeks
later no participant had the lowest score possible (0 %), and
12 out of 81 (14.8 %) participants had the highest possible
score at the second assessment. Seven of the 12 had the
highest score at both assessments.
Time to complete the 13-item SFInX is estimated at
5 to 7 min once the tester is familiar with the test
administration. Training to use the SFInX for health
professionals who manage patients with a proximal
fracture of the humerus is not required. However, fa-
miliarisation should include reading the SFInX manualal score absolute agreement between raters (full black dots represent
Table 5 Intra-rater and inter-rater reliability and measurement error estimates of the SFInX
Bland-Altman analysis
Reliability ICC2,1 (95 % CI) SEM MDC95 Mean difference (95 % CI) Limits of Agreement
Intra-rater 0.96 (0.94 to 0.97) 3.9 10.8 0.1 (−1.2 to 1.3) −10.6 to 10.8
Inter-rater 0.91 (0.63 to 0.97) 5.8 16.1 5.1 (2.1 to 8.0) −7.3 to 17.4
Kappa %
Inter-rater item agreement 0.42 to 1.00 40-100 %
Dichotomous items (n = 5) 0.62 to 1.00 90-100 %
Polytomous items (n = 8) 0.42 to 0.92 40-95 %
ICC Intra-class correlation coefficient, CI Confidence Interval, MDC Minimal Detectable Change, SEM Standard Error of Measurement
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testing (247 assessments) we used a 19-item development
version of the SFInX (mean 8 min 7 s [(SD1min 51 s;
range 2 min to 14 min 13 s]), which still included removed
items that took longer to complete, such as walking and
turning/rolling in bed [15, 16]. A SFInX assessment will
therefore be shorter on average, but also depend on the
ability and mobility of the individual patient.
Several objects were required to make testing functional
and simulate daily activities: a cup, objects of 1.5, 3 and
6 kg, a (soccer) ball and a (shopping) bag. Suggestions for
objects have been made in the SFInX manual [15], (http://
sfinx.blogs.latrobe.edu.au/)].Discussion
This study provided evidence of measurement properties
for the SFInX as a feasible and reliable outcome measure
of ‘shoulder function’, which is capable of detecting
clinically important changes in ‘shoulder function’ of
people recovering from a proximal humeral fracture.
This study provides evidence for the construct validity of
the SFInX in the form of convergent, discriminant and
known-groups validity testing.
The SFInX was developed as a clinician-observed out-
come measure (COOM). This type of administration is
new in shoulder function measurement and has benefits
over other types of outcome administration. For example,
available performance-based shoulder measures such as
the FIT-HaNSA and simple shoulder endurance test
[48, 49] focus mainly on endurance (timing and specific
weights) and are limited clinically and functionally by
not covering a range of tasks. Also, clinician-administered
measures such as the Constant Score [27, 28] and
American Shoulder and Elbow Surgeons’ Examination
Scale [50] have limitations as outcome measure. They
combine patient-reported and clinician-administered
components, incorporate multiple domains of function-
ing into a single score [11], and have arbitrary scorings
to their components [12]. Such content and structural
issues may raise concerns about accurate reflection ofshoulder function and may not yield a score that is
easily interpretable.
Patient-reported outcome measures (PROMs) are widely
used and greatly valued. However, PROMs are influenced
by several factors. For example, outcomes of PROMs focus-
sing on ‘function’ have been strongly associated with per-
ceived levels of pain compared with actual function [9, 51],
and provide information on patient perception rather than
actual ability or physical performance [7, 8, 52]. Also,
factors such as anxiety and fear-avoidance might influence
self-reported physical function [53]. PROMs may provide
different information to a person’s performance ability. It is
therefore advised to use the SFInX as a COOM of actual
ability and well developed PROMs together for comprehen-
sive measurement of shoulder function.
Reliability analysis showed that for both the intra-rater
and inter-rater reliability ICCs were over 0.90, which is
considered good for use in groups, for example at an
organisational level or in research projects, and in individ-
ual patients [36, 54]. This was confirmed by a low SEM of
3.9 out of 100 points. The MDC95 informs that we can be
95 % sure that a change of 10.8 SFInX points or more ex-
ceeds measurement error. These values are similar when
compared to another unidimensional clinician-observed
outcome measure: the de Morton Mobility Index [55]. For
other shoulder measures such as the DASH and Constant
Score SEMs of 6.5 and 4.5 out of 100 points have previ-
ously been found in people with a proximal humeral frac-
ture [11] which indicate MDC95 values of 18 and 12.5
points respectively. From the inter-rater reliability study a
MDC95 of 16 points was found, which suggests that when
a second rater would evaluate a patient’s shoulder function
with the SFInX, a difference of 16 points would exceed
measurement error. However, this number included the
systematic error between raters of 5 points due to item 3.
Therefore, the error estimate of 12.3 points might be a
more accurate indicator for measurement error between
raters when item 3 would be more consistently scored or
when systematic error is taken into account. Comparing
the MCID of 10.3 (anchor-based method) or 11.7 (distri-
bution-based method) points with the MDC95 (10.8
van de Water et al. BMC Musculoskeletal Disorders  (2016) 17:295 Page 10 of 12points), it can be suggested that a difference in score of
11–12 points can be considered a clinically important
change that exceeds measurement error. Although some
argue that the distribution-based method of MCID is
more related to minimal detectable change than MCID
[56], it is an accepted method for MCID estimation [36].
In addition, the MCID is a variable concept depending
on baseline scores, directions of change and methods
used. Therefore, different methods were used to esti-
mate the MCID and MCID values were interpreted as
an estimated range of scores required to be considered
clinically important.
The design and measurement properties of the SFInX
indicate that it can be used to monitor a person’s ‘shoulder
function’ from as early as first use of the arm until inde-
pendent performance of daily tasks for self-care and
around the house. Validated in a sample of people from
five weeks up to one year post-fracture and with a large
range of abilities, the SFInX may be valuable for early
measurement during rehabilitation, monitoring progress
in patients and as a potential indicator for discharge from
health care services such as physical therapy.
Similarly, the SFInX can be used as an evaluative in-
strument in clinical research investigating the clinical
management in people with a proximal humeral frac-
ture. High-quality evidence and treatment guidelines are
currently lacking [57–59], indicating that randomised
controlled trials evaluating management strategies in
this population are required. Functional outcomes mea-
sured by well-developed measures such as the clinician-
observed SFInX, should be used.
Limitations
Some limitations in the study require consideration.
The low agreement between raters on item 3 ‘washing
the back of the opposite shoulder’ (k = 0.42) may have
negatively influenced the reliability estimations of the
SFInX. The item’s category descriptions may have con-
tributed to the different ratings and were altered after
analysis. The final 13-item SFInX (Appendix) [15],
(http://sfinx.blogs.latrobe.edu.au/), contains the re-worded
category descriptions for item 3. Although inter-rater
agreement and reliability showed improvement when
re-analysed with data from item 3 assumed equal, future
reliability testing with the revised category descriptions
is required.
The small sample size of the inter-rater reliability
study can be seen in light of preliminary estimations.
It is recommended to have sample sizes of approxi-
mately 50 patients for estimations with smaller con-
fidence intervals [39]. Future studies with multiple
raters in clinical settings or video recordings are
needed to confirm the estimations from this smaller
inter-rater reliability study.The study sample varied with regards to time after
fracture at study inclusion. Although this allowed for
variety in shoulder function for the development of the
SFInX, future prospective studies could concentrate on
following up patients from admission to discharge while
also recording more details on treatment than recorded
in the current study. This could benefit further analyses
on longitudinal validity (responsiveness), MCID and
discharge predictions of the SFInX in a homogenous
sample in relation to the clinical course. Additionally,
further Rasch analyses could be carried out with stratifi-
cation of patients at different stages of healing after frac-
ture to confirm the SFInX as a unidimensional and
invariant scale for this population.
Conclusion
The new Shoulder Function Index is sufficiently reliable
and is valid for clinicians to monitor shoulder function
of individuals and groups of people with a proximal
humeral fracture. With its construct of measuring shoul-
der function as the ability to perform activities in which
the shoulder is involved, it can now be used as an evalu-
ative outcome measure in clinical and research settings.
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